# Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

> **NCT01235845** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Qingdao University** · enrollment: 30 (estimated)

## Conditions studied

- Malignant Glioma

## Interventions

- **BIOLOGICAL:** Biological: DC activated CIK combined with DC

## Key facts

- **NCT ID:** NCT01235845
- **Lead sponsor:** Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235845, "Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01235845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*